How many clinical trials are tracked of lurasidone?

25 trials are tracked, 3 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

lurasidone

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of lurasidone

25 trials tracked of lurasidone: 22 in phase 3 or 4 and 3 with published results. The most-cited published study has 127 citations.

25Trials tracked

22Phase 3 & 4

0Recruiting

3With published results

Phase distribution

Phase 4 3 Phase 3 19 Phase 2 2 Phase 1 1

Phase 3 Lurasidone Pediatric Bipolar Study Completed · 127 cited
Phase 4 High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia Completed · 6 cited
Phase 4 Lurasidone Effects on Tissue Glutamate in Schizophrenia Completed
Phase 4 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder Completed
Phase 3 Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Completed
Phase 3 This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Completed

Show 19 more trials

Phase 3 Lurasidone Extended Use Study Completed
Phase 3 Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia Completed
Phase 3 Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia Completed
Phase 3 PEARL Schizophrenia Maintenance Completed
Phase 3 A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder Completed
Phase 3 Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose Completed
Phase 3 Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. Completed
Phase 3 A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents Completed
Phase 3 Lurasidone Low-Dose - High-Dose Study Study Completed
Phase 3 Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression Completed
Phase 3 A Twelve Week, Open Label Extension Study in Patients With Schizophrenia Completed
Phase 3 Lurasidone Pediatric Autism Study Completed
Phase 3 Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia Completed
Phase 3 Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression Completed
Phase 3 Major Depressive Disorder With Mixed Features - Extension Completed
Phase 3 Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) Completed
Phase 2 A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia Completed
Phase 2 A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication Completed
Phase 1 Lurasidone Pediatric Pharmacokinetics Study Completed

Showing the 25 most-cited and recently-updated of 25 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.